4//SEC Filing
Koppel Adam 4
Accession 0000950170-24-070855
CIK 0001805387other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:12 PM ET
Size
6.2 KB
Accession
0000950170-24-070855
Insider Transaction Report
Form 4
Koppel Adam
Director10% Owner
Transactions
- Award
Common Stock
2024-06-05+10,461→ 13,743 total
Holdings
- 65,679,781(indirect: See footnotes)
Common Stock
Footnotes (2)
- [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 100% of the RSUs subject to this grant shall vest upon the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the 2025 annual meeting of stockholders of the Company.
- [F2]Represents shares of the Issuer's common stock held directly by BC Perception Holdings, LP ("BC Perception"). Adam Koppel is a Partner of Bain Capital Life Sciences Investors, LLC. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001578965
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 5:12 PM ET
- Size
- 6.2 KB